Sphera Funds Management’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$7.15M Sell
2022
Q2
$8.87M Buy
2022
Q1
$7.86M Sell
2021
Q4
$10.8M Buy